SCHEMBL5145889

SCHEMBL5145889

CC1(C)NC(=O)N(CCNc2ncc(Br)c(-c3cc4ccncc4s3)n2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CDK2 P24941 1/20 0.33
CLK1 P49759 1/20 0.33
HTT P42858 2/20 0.33
MAPT P10636 1/20 0.33
NAMPT P43490 2/20 0.31
PLA2G7 Q13093 1/20 0.31
CYP2A6 P11509 1/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
GAA P10253 1/20 0.30
ALOX15 P16050 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
FPR2 P25090 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147360 0.93 CYP2A6 (0.35) ALDH1A1SMN1; SMN2NPC1RAB9ACDK2
SCHEMBL5147380 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5147498 0.86 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5147313 0.85 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL2975102 0.85 FGFR1 (0.32) NAMPTCYP2A6
SCHEMBL5147458 0.84 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2NPC1RAB9ACDK2
SCHEMBL5148335 0.84 PDE3B (0.36) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5147302 0.83 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5179917 0.83 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5147462 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed